INFUSE BONE GRAFT 7510200

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a consumer report with the FDA on 2020-01-30 for INFUSE BONE GRAFT 7510200 manufactured by Medtronic Sofamor Danek Usa, Inc.

Event Text Entries

[187369254] Neither the device nor films of applicable imaging studies were returned to the manufacturer for evaluation. Therefore, we are unable to determine the definitive cause of the reported event. If information is provided in the future, a supplemental report will be issued.
Patient Sequence No: 1, Text Type: N, H10


[187369255] It was reported that patient underwent two surgeries ((b)(6) 2011 and (b)(6) 2011) and experienced post-op injury. (b)(6) 2011: the patient underwent anterior exposure of l5-s1 interspace for disc excision and fusion. The findings were: patient was brought to the operating room, placed supine on the operating table. General endotracheal anesthesia was induced. He was then prepped and draped in the usual sterile manner. The operation was begun through a left paramedian incision. Dissection was carried down to the external oblique aponeurosis. The external oblique aponeurosis was then opened, and the rectus muscle was reflected medially. The retroperitoneum was then entered laterally. Using a combination of blunt and sharp dissection the peritoneal cavity was mobilized medially exposing first the external iliac artery and common iliac artery and subsequently the common iliac vein. The l5-s1 disc space was then exposed. The middle sacral artery' was identified and this was cauterized. Dr. Pencek then entered the field and assisted with final exposure by placing the endoring. Once adequate exposure was obtained dr. Pencek began the disc excision and fusion. Please see his dictation regarding this. I did assist him with this part of the procedure. Once the disc excision and fusion was completed the retroperitoneal was inspected and there appeared to be no bleeding from the great vessels. The peritoneal cavity was then allowed to return to its normal anatomic position. The retroperitoneum was examined and the transversalis fascia did not appear adequate to be closed. We therefore decided just to close the external oblique aponeurosis. This was done with interrupted #1 pds sutures. The wound was then irrigated and then closed in layers with 2-0 and 3-0 vicryl sutures. The skin was closed with a running subcuticular suture and dermabond. A sterile dressing was applied. The patient tolerated the procedure well and there were no complications. Estimated blood loss was 100. Needle and sponge count was correct. Specimens? None. The patient was taken to recovery in stable condition with strong palpable left pedal pulses. (b)(6) 2011: the patient underwent ct lumbar spine without contrast. The findings were: there is no fracture or bone destruction. Posterior fixation screws are now identified at the l5 and s1 levels. The left-sided screw in the upper sacrum projects slightly beyond the anterior cortex of the sacrum. The disc implant at l5-s1 is unchanged. The impression were: posterior fixation screws appearing at the l5 and s1 levels. The left-sided screw in the upper sacrum projects slightly beyond the anterior cortex of the sacrum. (b)(6) 2011: the patient underwent ct lumbar spine without contrast. The findings were: there is no fracture or bone destruction. Posterior fixation screws are now identified at the l5 and s1 levels. The left sided screw in the upper sacrum projects slightly beyond the anterior cortex of the sacrum. The disc implant at l5-s1 is unchanged. The impressions were: posterior fixation screws appearing at the l5 and s1 levels. The left-sided screw in the upper sacrum projects slightly beyond the anterior cortex of the sacrum. (b)(6) 2016: the patient underwent rad/xr lumbar spine. The findings were: screw noted in the body of l4 and l5. These are seen posteriorly. One screw is noted on each side joined by vertical rods on each side. In addition metallic pins noted in the space between l5 and s1. No recent fracture seen. Sacrum is intact. The impression were: posterior screw noted in the body of l4 and l5 with vertical rod on each side. These are postoperative changes. No other significant findings noted. No recent fracture seen.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number1030489-2020-00114
MDR Report Key9646319
Report SourceCONSUMER
Date Received2020-01-30
Date of Report2020-01-30
Date Mfgr Received2020-01-03
Device Manufacturer Date2010-10-28
Date Added to Maude2020-01-30
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactSTACIE ZIEMBA
Manufacturer Street1800 PYRAMID PLACE
Manufacturer CityMEMPHIS TN 38132
Manufacturer CountryUS
Manufacturer Postal38132
Manufacturer Phone9013963133
Manufacturer G1MEDTRONIC SOFAMOR DANEK USA, INC
Manufacturer Street4340 SWINEA RD
Manufacturer CityMEMPHIS TN 38118
Manufacturer CountryUS
Manufacturer Postal Code38118
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameINFUSE BONE GRAFT
Generic NameFILLER, RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN, COLLAGEN SCAFFOLD WITH MET
Product CodeNEK
Date Received2020-01-30
Model NumberNA
Catalog Number7510200
Lot NumberM110911AAF
Device Expiration Date2013-08-01
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device Eval'ed by MfgrN
Device Sequence No1
Device Event Key0
ManufacturerMEDTRONIC SOFAMOR DANEK USA, INC
Manufacturer Address4340 SWINEA RD MEMPHIS TN 38118 US 38118


Patients

Patient NumberTreatmentOutcomeDate
101. Other 2020-01-30

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.